Wang Lü-Ya, Lin Jie, Liu Shu, Chen Bao-Sheng
Beijing Institute of Heart Lung and Blood Vessel Diseases-Beijing Anzhen Hospital, Affiliated of Capital University of Medical Sciences, Beijing 100029, China.
Yi Chuan Xue Bao. 2005 Jul;32(7):770-7.
Familial hypercholesterolemia (FH),which is caused by low-density lipoprotein (LDL) receptor mutation, leads to LDL-R dysfunction and high plasma LDL level and early onset of cardiovascular disease. LDL-R mutation has been regarded as the only cause of FH phenotype. However, evidences from recent studies showed that another six gene mutations can also result in FH like phenotype through different mechanism. Further studies on these genes will clarify the mechanism of plasma LDL regulation and provide the molecular basis for the diagnosis and treatment of patients with FH-like phenotype. This review summarizes recent studies on the molecular basis of FH-like phenotype heterogeneity in the hope of drawing more attention to the disease.
家族性高胆固醇血症(FH)由低密度脂蛋白(LDL)受体突变引起,导致LDL-R功能障碍、血浆LDL水平升高以及心血管疾病的早发。LDL-R突变一直被认为是FH表型的唯一原因。然而,最近的研究证据表明,另外六种基因突变也可通过不同机制导致类似FH的表型。对这些基因的进一步研究将阐明血浆LDL调节机制,并为具有类似FH表型患者的诊断和治疗提供分子基础。本综述总结了关于类似FH表型异质性分子基础的最新研究,希望引起对该疾病更多的关注。